Levodopa and carbidopa ( DrugBank: Carbidopa, Levodopa )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
6	パーキンソン病	5

6. パーキンソン病

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

diseases per page:

Showing 1 to 5 of 5 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05094050 (ClinicalTrials.gov)	January 18, 2022	20/10/2021	Study to Assess How ABBV-951 is Absorbed When Administered at Different Subcutaneous Sites of Adult ...	Parkinson's Disease: A Comparative Study of Levodopa and CarbidopaBioavailability Following Foslevod ...	Parkinson's Disease	Drug: ABBV-951	AbbVie	NULL	Active, not recruiting	30 Years	N/A	All	16	Phase 1	United States
2	NCT02096601 (ClinicalTrials.gov)	August 2014	18/3/2014	A Pharmacokinetic Study of ND0612 Delivered as a Continuous Subcutaneous in Parkinson's Disease Pati ...	A Phase I/II Pharmacokinetic (PK) Study of ND0612, a Liquid Formulation of Levodopa/Carbidopa (LD/CD ...	Parkinson's Disease	Drug: Levodopa and carbidopa SC solution;Drug: Oral levodopa and carbidopa	NeuroDerm Ltd.	Michael J. Fox Foundation for Parkinson's Research	Completed	30 Years	80 Years	All	16	Phase 1/Phase 2	United States;Israel
3	NCT01883505 (ClinicalTrials.gov)	December 2013	9/6/2013	A Phase 2a Study Followed to Evaluate the Safety, Tolerability and Levodopa Pharmacokinetics in Levo ...	A Phase 2a Multicentre Randomized Double Blind Placebo Controlled Study Followed by an Open Label Pe ...	Parkinson's Disease	Drug: Levodopa and carbidopa;Drug: Placebo	NeuroDerm Ltd.	NULL	Completed	30 Years	N/A	Both	30	Phase 2	Israel
4	NCT01725802 (ClinicalTrials.gov)	December 2012	4/11/2012	A Phase I/IIa Study of Safety, Tolerability and Plasma Concentration of Subcutaneous Continuously-de ...	A Phase I/IIa, Single Dose, Single-centre, Randomized, Crossover, Double-blind, Placebo-controlled S ...	Parkinson's Disease	Drug: levodopa and carbidopa solution for SC administration;Drug: Placebo	NeuroDerm Ltd.	NULL	Completed	30 Years	N/A	Both	8	Phase 1/Phase 2	Israel
5	NCT01484990 (ClinicalTrials.gov)	April 2010	28/7/2011	A Pharmacokinetic Study of Levodopa and CarbidopaIntestinal Gel in Subjects With Advanced Parkinson' ...	A Pharmacokinetic Study of Levodopa and CarbidopaIntestinal Gel in Subjects With Advanced Parkinson' ...	Parkinson Disease	Drug: Levodopa-Carbidopa	AbbVie	Quintiles, Inc.	Completed	30 Years	99 Years	All	19	Phase 1	Germany;Sweden

First Previous1Next Last